H1N1 vaccination in Canada and adjuvant

Is there something fishy between adjuvant and Gulf war syndrome or it is just me?


I did some google search on this subject and found some information I wanted to share.



Canadian authorities say to us that adjuvant has nothing to do with Gulf War syndrome since it was never used in vaccination against anthrax for military personel.(see link 1)
But If you look at link 2 it says that DoD (Departmant of Defence) in USA states that it doesn’t know if it was used or not . And if they say the don’t know what they put inside they soldiers usually means they not telling the true facts. As well from the same link 2 we can see that 1 of 7 soldiers got the Gulf War syndrome. Which is a lot.
And in the link number 3 we can see that Germany has 2 types of the vaccination one with adjuvant and one without. The one without is for all the government structure of germany and the one with for General public.
All this looks very strange for me.

p.s.
So as we know the vaccine we are getting in Canada has adjuvant. If I am not mistake only the pregnant people in Canada get the one without any adjuvant. The Question is why ?

Does anybody know it might be bad for pregnant women? Not really. But they say the research was never done on pregnant woman so they don’t know what side affects might occur. But the research was never done on the babies as well and the babies get the regular shot with adjuvant in Canada. I am to lazy to investigate it. But is my above statement is true?



Limk1

Q: What's in the adjuvant?

A: The product from GlaxoSmithKline, Canada's sole provider of H1N1 vaccine, called Arepanrix, uses an adjuvant called AS03, which consists of squalene (shark liver oil), DL-alpha-tocopherol (vitamin E) and polysorbate 80 (an emulsifier also used in ice cream). There are claims about the dangers of squalene but very little evidence to back them up. For example, it is claimed that the adjuvant used in the anthrax vaccine was to blame for Gulf War syndrome, but there was not adjuvant in that vaccine.
http://www.theglobeandmail.com/life/health/h1n1-swine-flu/your-h1n1-vaccine-questions-answered/article1348473/

Link2
"We Never Used Squalene in Vaccines"

Military officials have said all along that no Gulf War vaccines contained squalene. In August 1997, spokespersons for the DoD claimed that squalene "was not an adjuvant that was in any of the vaccines that were used by the Department of Defense,"3 and that "we never used squalene in vaccines" during the Gulf War. However, in a report4issued in March 1999, the General Accounting Office (GAD) - the investigative arm of Congress - stated:

We cannot say definitively whether or not Gulf War-era veterans were given vaccines with adjuvant formulations containing squalene for a number of reasons. Although DoD officials told us they did not administer such vaccines, they stated they did not have documentation on the process and results of decision-making related to the administration of vaccines at the time of the Gulf War. Also, some officials involved in the decisions were no longer employed with DoD at the time of our review, and we were either unable to locate them, or they declined to be interviewed.


A month after the GAO issued its 1999 report, the first hint that squalene might be linked to Gulf War syndrome appeared in an article in New Scientist magazine.5 Robert Garry, a virologist at Tulane University, tested more than 400 Gulf War veterans for antibodies to squalene and found that 95 percent of those with GWS had high levels of squalene antibodies.

Garry also tested a pair of volunteers who had received experimental herpes vaccines containing squalene in trials conducted by the National Institutes of Health. Both had high levels of squalene antibodies and also suffered from GWS-type symptoms.

In February, the peer-reviewed journal Experimental and Molecular Pathology6 published a study written by Garry's team at Tulane University and Dr. Pamela Asa, an immunologist from Tennessee. Dr. Asa was one of the first health professionals to advance the theory that Gulf War syndrome might be an autoimmune disorder caused by experimental vaccinations.

The research included blinded and unblinded studies. In the blinded study, 56 Gulf War-era veterans and military personnel who were on active service in 1990-91 were tested for squalene. Of those 56, 38 had been deployed to the Persian Gulf and had GWS-type symptoms; 12 had been deployed but were healthy; and six had not been deployed but were nevertheless ill.

The researchers found that among the 38 ill veterans who had been deployed, 36 (94.7 percent) tested positive for squalene antibodies. None of the deployed healthy individuals, however, tested positive.

Furthermore, all six subjects who were ill, but had not been sent to the Gulf, also had squalene antibodies. While they did not serve in the war, they had received the same type and number of vaccinations given to Gulf War troops.

To see whether squalene antibodies might be a marker for other types of autoimmune diseases, the researchers also tested groups of patients with lupus and chronic fatigue syndrome, as well as a small sample from the general population. Only 15 percent of those with chronic fatigue tested positive for squalene; only 10 percent of those with lupus tested positive; and only five percent of the general population had squalene antibodies.

The Tulane study made no conclusion about whether Gulf War vaccines contained squalene, what may have produced the antibodies, or what role they play in Gulf War syndrome. Still, it is hoped that the research conducted by Garry and Asa will prompt others to investigate the role of vaccinations in Gulf War syndrome and the safety of vaccines that contain squalene.

"We don't know what caused the immune system to produce anti-squalene antibodies in the Gulf War veterans, but this study shows that the antibodies are indeed there," observed Dr. Russell Wilson, president of Autoimmune Technologies, which helped market the study. Dr. Wilson does not believe that the antibodies were the result of a reaction to squalene added to vaccines. "That possibility must still be formally ruled out,"7 he concluded.

Approximately 700,000 Americans served in the Gulf War between 1990-91. One hundred and forty-eight Americans were killed in action; 467 were wounded. The Department of Veterans Affairs estimates that as many as 100,000 veterans may be suffering from Gulf War syndrome or related symptoms, and that approximately 6,500 soldiers have died since the war's conclusion, including more than 1,300 soldiers between the ages of 18-24.8
http://www.chiroweb.com/mpacms/dc/article.php?id=31730

--------------------------------------



Link 3
In Germany, A Better H1N1 Vaccine For Politicians?
Time.com ^ | October 27, 2009 | Tristana Moore

Posted on October 27, 2009 3:37:31 PM by khnyny

Critics are calling it a two-tier health system — one for the politically well-connected, another for the hoi polloi. As Germany launched its mass vaccination program against the H1N1 flu virus on Monday, the government found itself fending off accusations of favoritism by offering one vaccine believed to have fewer side effects to civil servants, politicians and soldiers, and another potentially riskier vaccine to everyone else. The government had hoped that Germans would rush to health clinics to receive vaccinations against the rapidly spreading disease, but the rising anger over the different doses may now cause many people to shy away.

Amid growing fears over a possible global flu pandemic, the German government prepared for its mass vaccination campaign earlier this year by ordering 50 million doses of the Pandemrix vaccine, which would be enough for a double dose for 25 million people, around a third of the population. The vaccine, manufactured by GlaxoSmithKline, contains an immune-enhancing chemical compound, known as an adjuvant, whose side effects are not yet entirely known. Then, after a report was leaked to the German media last week, the Interior Ministry confirmed that it had ordered a different vaccine, Celvapan, for government officials and the military. Celvapan, which is made by the U.S. pharmaceutical giant Baxter, does not contain an adjuvant and is believed to have fewer side effects than Pandemrix.

http://www.freerepublic.com/focus/news/2372227/posts